Production (Stage)
REGENXBIO Inc.
RGNX
$10.10
-$0.03-0.30%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 111.88% | 14.11% | -12.47% | 16.33% | -0.70% |
Total Depreciation and Amortization | -1.69% | 1.57% | -2.22% | -3.09% | -3.58% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 84.93% | -56.95% | 20.61% | -36.91% | 38.28% |
Change in Net Operating Assets | 40.79% | 92.07% | 250.37% | 50.52% | -188.44% |
Cash from Operations | 206.34% | 22.01% | 10.88% | 17.96% | -36.05% |
Capital Expenditure | 5.10% | -230.98% | 31.22% | 14.90% | 50.53% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 10.68% | -18.25% | 24,455.34% | -98.50% | -60.85% |
Cash from Investing | 11.10% | -19.87% | 18,852.99% | -102.03% | -61.20% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 1,102.63% | -94.10% | 235.42% | -99.86% | 63,486.60% |
Repurchase of Common Stock | -- | -- | -- | 100.00% | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 26.19% | 32.37% | -19.34% | 14.42% | 7.48% |
Cash from Financing | 25.14% | 28.71% | -14.95% | -107.82% | 1,109.24% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 7,884.38% | 179.18% | 97.92% | -170.37% | 518.46% |